| |
| |
|
| Insider
Information: |
Labarre Michael J. |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
168,176 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,324,712 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
168,176 |
|
|
| Total
Value |
$8,324,712 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -27.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
|
2024-05-22 |
168,176 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
106 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical OfficerOf |
• – – |
2020-01-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
154,223 |
|
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,559 |
165,782 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-02-03 |
4 |
D |
$19.21 |
$82,392 |
D/D |
(4,289) |
161,493 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-02-12 |
4 |
D |
$20.00 |
$54,500 |
D/D |
(2,725) |
166,651 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,883 |
169,376 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-02-14 |
4 |
D |
$21.10 |
$42,095 |
D/D |
(1,995) |
170,428 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,772 |
172,423 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-02-22 |
4 |
D |
$21.83 |
$66,451 |
D/D |
(3,044) |
176,187 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,803 |
179,231 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-05-20 |
4 |
AS |
$23.80 |
$509,075 |
D/D |
(21,387) |
176,187 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-05-20 |
4 |
OE |
$7.14 |
$152,703 |
D/D |
21,387 |
197,574 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-05-22 |
4 |
OE |
$7.14 |
$132,897 |
D/D |
18,613 |
194,800 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-07-20 |
4 |
AS |
$29.01 |
$348,072 |
D/D |
(12,000) |
182,800 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-08-20 |
4 |
AS |
$28.30 |
$339,564 |
D/D |
(12,000) |
170,800 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-09-21 |
4 |
AS |
$26.91 |
$322,884 |
D/D |
(12,000) |
158,800 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-10-20 |
4 |
AS |
$30.43 |
$365,148 |
D/D |
(12,000) |
146,800 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-11-20 |
4 |
AS |
$38.24 |
$465,176 |
D/D |
(12,000) |
134,800 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-12-21 |
4 |
AS |
$42.54 |
$510,919 |
D/D |
(12,000) |
122,800 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-10 |
4 |
D |
$50.60 |
$147,044 |
D/D |
(2,906) |
128,028 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,134 |
130,934 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-12 |
4 |
D |
$49.84 |
$135,814 |
D/D |
(2,725) |
133,186 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,883 |
135,911 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,771 |
138,957 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-14 |
4 |
D |
$49.84 |
$113,236 |
D/D |
(2,272) |
136,685 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-22 |
4 |
D |
$48.69 |
$212,483 |
D/D |
(4,364) |
141,124 |
0 |
- |
|
106 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
